查找临床试验
已按「心力衰竭」检索，对应国际通用词 heart failure
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 11:18，每 5 分钟自动同步EACH-ADHF: Early Comprehensive Rehabilitation in Patients With ADHF
China
年龄 18 Years – 80 Years
Guangdong Provincial People's Hospital
Clinical Outcomes of Cardiovascular Disease
China
年龄 18 Years – 80 Years
Xinjiang Medical University
Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity
China
年龄 18 Years – 80 Years
Shandong Suncadia Medicine Co., Ltd.
Clinical Efficacy and Safety of Left Bundle Branch Area Pacing Using Quantitative Guidance of Multimodal Data in the Treatment of Heart Failure
China
年龄 18 Years – 80 Years
Second Affiliated Hospital of Nanchang University
MItral Regurgitation Risk Assessment and CLinical modElling
China
年龄 18 Years – 不限
Sun Yat-sen University
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
China
年龄 18 Years – 不限
Fujian Shengdi Pharmaceutical Co., Ltd.
Electroacupuncture at ST36 for Reducing Postoperative Inflammation After Cardiac Surgery With Cardiopulmonary Bypass
China
年龄 18 Years – 不限
Sir Run Run Shaw Hospital
A Pilot Randomized Controlled Trial Comparing Core Exercise, Aerobic Exercise, and Combined Exercise in Patients Undergoing Phase II Cardiac Rehabilitation.
Taiwan
年龄 18 Years – 不限
National Taiwan University Hospital
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
United States、Argentina、Belgium、Brazil、Bulgaria 等 12 国
年龄 18 Years – 不限
Boehringer Ingelheim
PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy
China
年龄 18 Years – 85 Years
Sinotau Pharmaceutical Group
A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
China
年龄 18 Years – 不限
Innovent Biologics (Suzhou) Co. Ltd.
Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure
China
年龄 18 Years – 不限
Shenzhen Core Medical Technology CO.,LTD.